Results
|
1.
|
|
|
2.
|
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). [electronic resource] by
- Majem, M
- García-Martínez, E
- Martinez, M
- Muñoz-Couselo, E
- Rodriguez-Abreu, D
- Alvarez, R
- Arance, A
- Berrocal, A
- de la Cruz-Merino, L
- Lopez-Martin, J A
Producer: 20201030
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 22
Availability: No items available.
|
|
3.
|
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. [electronic resource] by
- Serrano, C
- Cortés, J
- De Mattos-Arruda, L
- Bellet, M
- Gómez, P
- Saura, C
- Pérez, J
- Vidal, M
- Muñoz-Couselo, E
- Carreras, M J
- Sánchez-Ollé, G
- Tabernero, J
- Baselga, J
- Di Cosimo, S
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 07 2019
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
4.
|
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. [electronic resource] by
- Serrano, C
- Cortés, J
- De Mattos-Arruda, L
- Bellet, M
- Gómez, P
- Saura, C
- Pérez, J
- Vidal, M
- Muñoz-Couselo, E
- Carreras, M J
- Sánchez-Ollé, G
- Tabernero, J
- Baselga, J
- Di Cosimo, S
Producer: 20120713
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
5.
|
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study. [electronic resource] by
- Schmid, P
- Salgado, R
- Park, Y H
- Muñoz-Couselo, E
- Kim, S B
- Sohn, J
- Im, S-A
- Foukakis, T
- Kuemmel, S
- Dent, R
- Yin, L
- Wang, A
- Tryfonidis, K
- Karantza, V
- Cortés, J
- Loi, S
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
6.
|
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study. [electronic resource] by
- Gavilá, J
- De La Haba, J
- Bermejo, B
- Rodríguez-Lescure, Á
- Antón, A
- Ciruelos, E
- Brunet, J
- Muñoz-Couselo, E
- Santisteban, M
- Rodríguez Sánchez, C A
- Santaballa, A
- Sánchez Rovira, P
- García Sáenz, J Á
- Ruiz-Borrego, M
- Guerrero-Zotano, A L
- Huerta, M
- Cotes-Sanchís, A
- Lao Romera, J
- Aguirre, E
- Cortés, J
- Llombart-Cussac, A
Producer: 20201116
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 22
Availability: No items available.
|